Research News and Research

RSS

Preclinical data for potent IDO pathway inhibitor presented at AACR 2013 annual meeting

NewLink Genetics Corporation, a biopharmaceutical company primarily focused on discovering, developing and commercializing immunotherapeutic products in oncology, announced today that the company presented preclinical data for NLG919, a potent IDO (indoleamine-(2,3)-dioxygenase) pathway inhibitor, at the American Association for Cancer Research 2013 annual meeting.

8 Apr 2013

First Edition: April 8, 2013

Today's headlines include reports about the politics surrounding the Wednesday unveiling of President Barack Obama's budget as well as other news about the health law's implementation.

8 Apr 2013

Pancreatic Cancer Action Network researchers to participate in Rally for Medical Research

Researchers and advocates from the Pancreatic Cancer Action Network will join nearly 200 national organizations today in demonstrating their concern about the impact of sequestration on cancer research during the Rally for Medical Research at 11 AM on the steps of the Carnegie Library in Washington, D.C.

8 Apr 2013

Business Network Services from Anglia Ruskin: an interview with Prof Young

The Anglia Ruskin Medtech Campus Business Network Services have been developed in partnership with Chelmsford City Council, Harlow District Council and Southend-on-Sea Borough Council as part of plans to form the largest MedTech cluster in the UK over three development sites in Essex.

8 Apr 2013

New issue of Global Health Diplomacy Network's 'Health Diplomacy Monitor' available online

Volume 4 Issue 2 of the Global Health Diplomacy Network's "Health Diplomacy Monitor" is now available online.

8 Apr 2013

Gene behind Vel blood group discovered

Researchers have uncovered the gene at the root of a human blood group that has remained a mystery for the past 60 years. They showed that a genetic deletion on this gene is responsible for the lack of this blood group in some people.

8 Apr 2013

Untested products sold in stores during patent medicine era, study shows

Scientists provided a glimpse today based on an analysis of a museum collection of patent medicines used in turn-of-the-century America.

8 Apr 2013

Amakem backs new Chair of Ophthalmology Translational Research at KU Leuven

Amakem NV, a kinase platform company focusing on ophthalmology, today announces it has sponsored a new Chair of Ophthalmology Translational Research at the Catholic University Leuven (KU Leuven), Belgium.

8 Apr 2013

Nine Nobel laureates to present their research at American Chemical Society meeting

At least nine Nobel laureates have research that will be presented here this week during the 245th National Meeting & Exposition of the American Chemical Society, the world's largest scientific society.

8 Apr 2013

Abstracts on Bristol-Myers Squibb's research in liver disease accepted for presentation

Bristol-Myers Squibb Company announced today that 14 abstracts on the Company's research in liver disease have been accepted for presentation at The International Liver CongressTM 2013, the 48th annual meeting of the European Association for the Study of the Liver, in Amsterdam, April 24 - 28.

8 Apr 2013

GenSight Biologics announces closing of €32 million Series A financing

GenSight Biologics, a biopharmaceutical company focused on the development of ophthalmic therapeutics using gene therapy, announced today the closing of a €32 million Series A financing.

8 Apr 2013

Pros and cons of new screening technologies for breast cancer

Although mammography, the gold standard of breast cancer screening, reduces breast cancer mortality, it has important limitations. Critics point to reduced sensitivity for women with dense breasts, a high rate of false positives leading to excessive biopsies, and concerns about long-term effects of repeated radiation.

8 Apr 2013

Research News and Research

Preclinical data for potent IDO pathway inhibitor presented at AACR 2013 annual meeting

First Edition: April 8, 2013

Pancreatic Cancer Action Network researchers to participate in Rally for Medical Research

Business Network Services from Anglia Ruskin: an interview with Prof Young

New issue of Global Health Diplomacy Network's 'Health Diplomacy Monitor' available online

Gene behind Vel blood group discovered

Untested products sold in stores during patent medicine era, study shows

Amakem backs new Chair of Ophthalmology Translational Research at KU Leuven

Nine Nobel laureates to present their research at American Chemical Society meeting

Abstracts on Bristol-Myers Squibb's research in liver disease accepted for presentation

GenSight Biologics announces closing of €32 million Series A financing

Pros and cons of new screening technologies for breast cancer

Fruit-juice-infused chocolate offers healthy treat

Study examines developmental delays in children within six weeks of CSE

Nektar Therapeutics presents positive results for NKTR-214 at AACR Annual Meeting

Researchers study influence of muscle types, body metabolism in diabetes

Study creates first detailed, up-to-date map of dengue distribution worldwide

Heart, blood and lungs have same receptors for sensing odors that exist in nose

Physician-researcher to lead pediatric Dream Team to create new treatments for childhood cancers

Research shows new separation process could help advance stem cell therapies

New Approach Methodologies, the 3Rs and Multimodal Imaging in Preclinical Research - eBook eBook

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery